Stockholm, Stockholm County, Sweden The fund was located in Europe if to be more exact in Sweden. The main department of described Corporate Investor is located in the Stockholm.
The usual cause for the fund is to invest in rounds with 6 partakers. Despite the FACIT.com, startups are often financed by Versant Ventures, TPG Biotech, Johnson & Johnson Development Corporation. The meaningful sponsors for the fund in investment in the same round are TPG Biotech, HealthCap, Genesys Capital. In the next rounds fund is usually obtained by Varian Medical Systems, TPG Biotech, Seroba Life Sciences.
Among the various public portfolio startups of the fund, we may underline Fusion Pharmaceuticals, Turnstone Biologics The fund has no exact preference in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Canada. Among the most popular fund investment industries, there are Pharmaceutical, Biotechnology.
The high activity for fund was in 2017. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year.
Related Funds
| Fund Name | Location |
| Animo Holdings Ltd. | - |
| Delavaco Capital | Florida, Fort Lauderdale, United States |
| FastTrackTech | Geneva, Geneve, Switzerland |
| King Street Partners | Charleston, South Carolina, United States |
| Lough Shore Investments | Belfast, Northern Ireland, United Kingdom |
| Nucleus Adventure Capital | New York, New York, United States |
| RSA Security | Bedford, Massachusetts, United States |
| Sweat Equity Partners | Houston, Texas, United States |
| UIL Limited | Bermuda, Devonshire, Hamilton |
| Xinjiang Investment Development Group | China, Shanxi, Xinjiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Fusion Pharmaceuticals | $105M | 01 Apr 2019 | Hamilton, Ontario, Canada | ||
Fusion Pharmaceuticals | $21M | 25 Sep 2017 | Hamilton, Ontario | ||
Fusion Pharmaceuticals | $25M | 23 Feb 2017 | Hamilton, Ontario, Canada | ||
Turnstone Biologics | $41M | 02 Nov 2016 | San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Fusion Pharmaceuticals | $105M | 01 Apr 2019 | Hamilton, Ontario, Canada | ||
Fusion Pharmaceuticals | $21M | 25 Sep 2017 | Hamilton, Ontario | ||
Fusion Pharmaceuticals | $25M | 23 Feb 2017 | Hamilton, Ontario, Canada | ||
Turnstone Biologics | $41M | 02 Nov 2016 | San Francisco, California, United States |
